FDA Inspection 1304742 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 3030809223

The FDA completed an inspection of BioLife Plasma Services LP on Feb 23, 2026 in Mesquite, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 23, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mesquite, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.